These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8565112)

  • 1. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein.
    Dzeletovic S; Babiker A; Lund E; Diczfalusy U
    Chem Phys Lipids; 1995 Nov; 78(2):119-28. PubMed ID: 8565112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major differences in oxysterol formation in human low density lipoproteins (LDLs) oxidized by *OH/O2*- free radicals or by copper.
    Zarev S; Thérond P; Bonnefont-Rousselot D; Beaudeux JL; Gardès-Albert M; Legrand A
    FEBS Lett; 1999 May; 451(2):103-8. PubMed ID: 10371147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages.
    Brown AJ; Dean RT; Jessup W
    J Lipid Res; 1996 Feb; 37(2):320-35. PubMed ID: 9026530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper.
    Patel RP; Diczfalusy U; Dzeletovic S; Wilson MT; Darley-Usmar VM
    J Lipid Res; 1996 Nov; 37(11):2361-71. PubMed ID: 8978488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxysterols cholest-5-ene-3 beta,4 alpha-diol, cholest-5-ene-3 beta,4 beta-diol and cholestane-3 beta,5 alpha,6 alpha-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques.
    Breuer O; Dzeletovic S; Lund E; Diczfalusy U
    Biochim Biophys Acta; 1996 Jul; 1302(2):145-52. PubMed ID: 8695664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper.
    Carpenter KL; Wilkins GM; Fussell B; Ballantine JA; Taylor SE; Mitchinson MJ; Leake DS
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):625-33. PubMed ID: 7999000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of human low-density lipoprotein by soybean 15-lipoxygenase in combination with copper (II) or met-myoglobin.
    O'Leary VJ; Graham A; Stone D; Darley-Usmar VM
    Free Radic Biol Med; 1996; 20(4):525-32. PubMed ID: 8904293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THP1 macrophages oxidized cholesterol, generating 7-derivative oxysterols specifically released by HDL.
    Chen Y; Arnal-Levron M; Lagarde M; Moulin P; Luquain-Costaz C; Delton I
    Steroids; 2015 Jul; 99(Pt B):212-8. PubMed ID: 25742736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of myeloperoxidase/nitrite-oxidized low-density lipoprotein toward endothelial cells is due to a high 7beta-hydroxycholesterol to 7-ketocholesterol ratio.
    Steffen Y; Wiswedel I; Peter D; Schewe T; Sies H
    Free Radic Biol Med; 2006 Oct; 41(7):1139-50. PubMed ID: 16962939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous transfer of phospholipid and cholesterol hydroperoxides between cell membranes and low-density lipoprotein: assessment of reaction kinetics and prooxidant effects.
    Vila A; Korytowski W; Girotti AW
    Biochemistry; 2002 Nov; 41(46):13705-16. PubMed ID: 12427033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits.
    Vine DF; Mamo CL; Beilin LJ; Mori TA; Croft KD
    J Lipid Res; 1998 Oct; 39(10):1995-2004. PubMed ID: 9788246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells.
    Pirillo A; Zhu W; Roma P; Galli G; Caruso D; Pellegatta F; Catapano AL
    FEBS Lett; 1999 Nov; 462(1-2):113-6. PubMed ID: 10580102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying susceptibility of different low density lipoproteins to oxidative modification.
    Jialal I; Freeman DA; Grundy SM
    Arterioscler Thromb; 1991; 11(3):482-8. PubMed ID: 2029490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC.
    Kritharides L; Jessup W; Gifford J; Dean RT
    Anal Biochem; 1993 Aug; 213(1):79-89. PubMed ID: 8238886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
    Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative degradation of cholesteryl esters in low-density lipoproteins: analysis by liquid chromatography-light scattering and protection by a new synthetic antioxidant, S20478.
    Arborati M; Benchorba D; Lesieur I; Bizot-Espiard JG; Guardiola-Lemaitre B; Chapman MJ; Ninio E
    Fundam Clin Pharmacol; 1997; 11(1):68-77. PubMed ID: 9182079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro.
    Schlotte V; Sevanian A; Hochstein P; Weithmann KU
    Free Radic Biol Med; 1998 Nov; 25(7):839-47. PubMed ID: 9823550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein.
    Chang YH; Abdalla DS; Sevanian A
    Free Radic Biol Med; 1997; 23(2):202-14. PubMed ID: 9199882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.
    Christen S; Thomas SR; Garner B; Stocker R
    J Clin Invest; 1994 May; 93(5):2149-58. PubMed ID: 8182147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.